NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader in non-invasive drug testing technology, today announced significant ...
Ribbon Bio GmbH, the DNA synthesis company, has been named A Best Place to Work 2025 by GenomeWeb in the mid-size category of 51-100 employees. This recognition reflects Ribbon’s commitment to ...
The sudden closure of two AmplifyBio facilities in central Ohio has triggered a lawsuit from a former employee, who claims the biotech firm failed to follow federal rules on layoff notifications. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback